Chemofit 250mg Tablet 1s

Chemofit 250mg Tablet 1s is primarily prescribed for cancer treatment It targets the epidermal growth factor receptor EGFR in both normal and cancer cells disrupting signals necessary for cancer cell growth Gefitinib a cancer medication inhibits cancer cell growth by targeting the EGFR found in both healthy and cancerous cells By blocking certain proteins associated with this receptor Gefitinib disrupts the communication pathways crucial for cancer cell growth and survival ultimately stopping the uncontrolled proliferation of cancer cells Follow your doctors prescribed dose and duration guidelines taking the medicine with or without food but maintaining a consistent daily time for optimal results Common side effects include diarrhea dry skin loss of appetite nausea rash stomatitis vomiting weakness and weight loss However there may be an increased risk of interstitial lung disease so patients should be monitored for symptoms such as cough difficulty breathing and fever Prompt medical attention is necessary if these symptoms occur Missed doses should be taken when remembered unless the next dose is approaching Skipping the missed dose and continuing with the regular dosing schedule is advisable to avoid doubling doses Consult your doctor for guidance on managing missed doses effectively